DR REDDYS LABORATORIES
|
DR REDDYS LABORATORIES Last 5 Year Income Statement History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| INCOME : | |||||
| Gross Sales | ₹32,644 Cr | ₹28,011 Cr | ₹24,670 Cr | ₹21,545 Cr | ₹19,048 Cr |
| Sales | ₹31,676 Cr | ₹27,189 Cr | ₹23,499 Cr | ₹20,549 Cr | ₹18,447 Cr |
| Job Work/ Contract Receipts | - | - | - | - | - |
| Processing Charges / Service Income | ₹922 Cr | ₹777 Cr | ₹1,128 Cr | ₹925 Cr | ₹552 Cr |
| Revenue from property development | - | - | - | - | - |
| Other Operational Income | ₹47 Cr | ₹46 Cr | ₹43 Cr | ₹71 Cr | ₹48 Cr |
| Less: Excise Duty | - | - | - | - | - |
| Net Sales | ₹32,644 Cr | ₹28,011 Cr | ₹24,670 Cr | ₹21,545 Cr | ₹19,048 Cr |
| EXPENDITURE : | |||||
| Increase/Decrease in Stock | ₹-545 Cr | ₹-681 Cr | ₹71 Cr | ₹-354 Cr | ₹-791 Cr |
| Raw Material Consumed | ₹10,525 Cr | ₹8,889 Cr | ₹7,587 Cr | ₹7,796 Cr | ₹6,869 Cr |
| Opening Raw Materials | ₹1,861 Cr | ₹1,186 Cr | ₹1,358 Cr | ₹1,215 Cr | ₹1,039 Cr |
| Purchases Raw Materials | ₹5,811 Cr | ₹5,165 Cr | ₹4,048 Cr | ₹4,455 Cr | ₹4,472 Cr |
| Closing Raw Materials | ₹1,988 Cr | ₹1,861 Cr | ₹1,186 Cr | ₹1,358 Cr | ₹1,215 Cr |
| Other Direct Purchases / Brought in cost | ₹4,841 Cr | ₹4,399 Cr | ₹3,367 Cr | ₹3,484 Cr | ₹2,574 Cr |
| Other raw material cost | - | - | - | - | - |
| Power & Fuel Cost | ₹563 Cr | ₹534 Cr | ₹477 Cr | ₹391 Cr | ₹321 Cr |
| Electricity & Power | ₹563 Cr | ₹534 Cr | ₹477 Cr | ₹391 Cr | ₹321 Cr |
| Oil, Fuel & Natural gas | - | - | - | - | - |
| Coals etc | - | - | - | - | - |
| Other power & fuel | - | - | - | - | - |
| Employee Cost | ₹5,580 Cr | ₹5,030 Cr | ₹4,647 Cr | ₹3,886 Cr | ₹3,630 Cr |
| Salaries, Wages & Bonus | ₹4,544 Cr | ₹4,125 Cr | ₹3,851 Cr | ₹3,215 Cr | ₹3,041 Cr |
| Contributions to EPF & Pension Funds | ₹451 Cr | ₹397 Cr | ₹362 Cr | ₹294 Cr | ₹260 Cr |
| Workmen and Staff Welfare Expenses | ₹506 Cr | ₹426 Cr | ₹370 Cr | ₹303 Cr | ₹255 Cr |
| Other Employees Cost | ₹80 Cr | ₹82 Cr | ₹64 Cr | ₹74 Cr | ₹74 Cr |
| Other Manufacturing Expenses | ₹2,563 Cr | ₹2,087 Cr | ₹1,739 Cr | ₹1,602 Cr | ₹1,574 Cr |
| Sub-contracted / Out sourced services | - | - | - | - | - |
| Processing Charges | - | - | - | - | - |
| Repairs and Maintenance | ₹567 Cr | ₹551 Cr | ₹492 Cr | ₹405 Cr | ₹333 Cr |
| Packing Material Consumed | - | - | - | - | - |
| Other Mfg Exp | ₹1,996 Cr | ₹1,536 Cr | ₹1,247 Cr | ₹1,197 Cr | ₹1,241 Cr |
| General and Administration Expenses | ₹2,173 Cr | ₹1,848 Cr | ₹1,498 Cr | ₹1,548 Cr | ₹1,252 Cr |
| Rent , Rates & Taxes | ₹259 Cr | ₹187 Cr | ₹157 Cr | ₹154 Cr | ₹143 Cr |
| Insurance | ₹107 Cr | ₹105 Cr | ₹109 Cr | ₹92 Cr | ₹68 Cr |
| Printing and stationery | - | - | - | - | - |
| Professional and legal fees | ₹936 Cr | ₹855 Cr | ₹610 Cr | ₹659 Cr | ₹510 Cr |
| Traveling and conveyance | ₹332 Cr | ₹297 Cr | ₹253 Cr | ₹139 Cr | ₹100 Cr |
| Other Administration | ₹538 Cr | ₹404 Cr | ₹368 Cr | ₹505 Cr | ₹432 Cr |
| Selling and Distribution Expenses | ₹2,926 Cr | ₹2,248 Cr | ₹1,989 Cr | ₹1,919 Cr | ₹1,568 Cr |
| Advertisement & Sales Promotion | ₹335 Cr | ₹393 Cr | ₹244 Cr | ₹217 Cr | ₹164 Cr |
| Sales Commissions & Incentives | ₹44 Cr | ₹36 Cr | ₹50 Cr | ₹182 Cr | ₹45 Cr |
| Freight and Forwarding | ₹757 Cr | ₹547 Cr | ₹604 Cr | ₹541 Cr | ₹587 Cr |
| Handling and Clearing Charges | - | - | - | - | - |
| Other Selling Expenses | ₹1,790 Cr | ₹1,272 Cr | ₹1,091 Cr | ₹980 Cr | ₹772 Cr |
| Miscellaneous Expenses | ₹313 Cr | ₹122 Cr | ₹314 Cr | ₹990 Cr | ₹754 Cr |
| Bad debts /advances written off | - | - | - | - | - |
| Provision for doubtful debts | ₹16 Cr | ₹28 Cr | ₹21 Cr | ₹7.30 Cr | ₹23 Cr |
| Losson disposal of fixed assets(net) | - | - | ₹121 Cr | - | ₹4.20 Cr |
| Losson foreign exchange fluctuations | - | - | - | - | - |
| Losson sale of non-trade current investments | - | - | - | - | - |
| Other Miscellaneous Expenses | ₹296 Cr | ₹94 Cr | ₹172 Cr | ₹983 Cr | ₹727 Cr |
| Less: Expenses Capitalised | - | - | - | - | - |
| Total Expenditure | ₹24,097 Cr | ₹20,078 Cr | ₹18,321 Cr | ₹17,778 Cr | ₹15,178 Cr |
| Operating Profit (Excl OI) | ₹8,547 Cr | ₹7,933 Cr | ₹6,349 Cr | ₹3,767 Cr | ₹3,870 Cr |
| Other Income | ₹1,097 Cr | ₹894 Cr | ₹1,056 Cr | ₹485 Cr | ₹291 Cr |
| Interest Received | ₹268 Cr | ₹228 Cr | ₹118 Cr | ₹97 Cr | ₹83 Cr |
| Dividend Received | - | - | - | - | - |
| Profit on sale of Fixed Assets | ₹151 Cr | ₹90 Cr | - | ₹112 Cr | - |
| Profits on sale of Investments | - | - | - | - | - |
| Provision Written Back | - | - | - | ₹0.30 Cr | - |
| Foreign Exchange Gains | ₹132 Cr | ₹27 Cr | ₹221 Cr | ₹183 Cr | ₹124 Cr |
| Others | ₹546 Cr | ₹549 Cr | ₹717 Cr | ₹93 Cr | ₹85 Cr |
| Operating Profit | ₹9,644 Cr | ₹8,827 Cr | ₹7,405 Cr | ₹4,252 Cr | ₹4,161 Cr |
| Interest | ₹283 Cr | ₹171 Cr | ₹143 Cr | ₹96 Cr | ₹97 Cr |
| InterestonDebenture / Bonds | - | - | - | - | - |
| Interest on Term Loan | ₹244 Cr | ₹146 Cr | ₹121 Cr | ₹96 Cr | ₹97 Cr |
| Intereston Fixed deposits | - | - | - | - | - |
| Bank Charges etc | - | - | - | - | - |
| Other Interest | ₹39 Cr | ₹26 Cr | ₹22 Cr | - | - |
| PBDT | ₹9,362 Cr | ₹8,656 Cr | ₹7,262 Cr | ₹4,156 Cr | ₹4,064 Cr |
| Depreciation | ₹1,704 Cr | ₹1,470 Cr | ₹1,250 Cr | ₹1,165 Cr | ₹1,229 Cr |
| Profit Before Taxation & Exceptional Items | ₹7,658 Cr | ₹7,186 Cr | ₹6,012 Cr | ₹2,991 Cr | ₹2,836 Cr |
| Exceptional Income / Expenses | - | - | - | - | - |
| Profit Before Tax | ₹7,680 Cr | ₹7,201 Cr | ₹6,049 Cr | ₹3,061 Cr | ₹2,884 Cr |
| Provision for Tax | ₹1,954 Cr | ₹1,623 Cr | ₹1,541 Cr | ₹879 Cr | ₹932 Cr |
| Current Income Tax | ₹2,258 Cr | ₹1,946 Cr | ₹814 Cr | ₹1,101 Cr | ₹817 Cr |
| Deferred Tax | ₹-304 Cr | ₹-323 Cr | ₹727 Cr | ₹-222 Cr | ₹115 Cr |
| Other taxes | - | - | - | - | - |
| Profit After Tax | ₹5,725 Cr | ₹5,578 Cr | ₹4,507 Cr | ₹2,183 Cr | ₹1,952 Cr |
| Extra items | - | - | - | - | - |
| Minority Interest | ₹-70 Cr | - | - | - | - |
| Share of Associate | - | - | - | - | - |
| Other Consolidated Items | - | - | - | - | - |
| Consolidated Net Profit | ₹5,655 Cr | ₹5,578 Cr | ₹4,507 Cr | ₹2,183 Cr | ₹1,952 Cr |
| Adjustments to PAT | - | - | - | - | - |
| Profit Balance B/F | ₹24,998 Cr | ₹20,023 Cr | ₹16,034 Cr | ₹14,240 Cr | ₹12,835 Cr |
| Appropriations | ₹30,653 Cr | ₹25,601 Cr | ₹20,541 Cr | ₹16,422 Cr | ₹14,787 Cr |
| General Reserves | - | - | - | - | - |
| Proposed Equity Dividend | - | - | - | - | - |
| Corporate dividend tax | - | - | - | - | - |
| Other Appropriation | ₹601 Cr | ₹603 Cr | ₹519 Cr | ₹388 Cr | ₹547 Cr |
| Equity Dividend % | ₹800.00 | ₹800.00 | ₹800.00 | ₹600.00 | ₹500.00 |
| Earnings Per Share | ₹67.81 | ₹334.41 | ₹270.55 | ₹131.16 | ₹117.28 |
| Adjusted EPS | ₹67.81 | ₹66.88 | ₹54.11 | ₹26.23 | ₹23.46 |
Compare Income Statement of peers of DR REDDYS LABORATORIES
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| DR REDDYS LABORATORIES | ₹102,651.4 Cr | -3.2% | -3.9% | -3% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹468,458.0 Cr | 0.7% | 8.1% | 16% | Stock Analytics | |
| DIVIS LABORATORIES | ₹193,383.0 Cr | 7% | 10.2% | 3.7% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹169,829.0 Cr | 2.5% | 11.3% | 49.6% | Stock Analytics | |
| CIPLA | ₹116,164.0 Cr | -0.3% | 4.1% | -3.3% | Stock Analytics | |
| MANKIND PHARMA | ₹105,174.0 Cr | 0.6% | 7% | 4.1% | Stock Analytics | |
DR REDDYS LABORATORIES Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| DR REDDYS LABORATORIES | -3.2% |
-3.9% |
-3% |
| SENSEX | 0.9% |
2.2% |
-7.5% |
You may also like the below Video Courses